Qilu Pharmaceutical Co., Ltd.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Qilu Pharmaceutical Co., Ltd.
RECRUITINGPhase 4NCT06940336
To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With...
The purpose of this study is to evaluate the efficacy and safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients with Transthyretin Amyloid Polyneuropathy
Sponsor: Qilu Pharmaceutical Co., Ltd.Enrolling: 151 location
Transthyretin Amyloid Polyneuropathy
RECRUITINGPhase 3NCT07062978
A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
This study is a multicenter, randomized, double-blind comparative study to valuating the efficacy and safety of QL1206 and Prolia® in postmenopausal women with osteoporosis at...
Sponsor: Qilu Pharmaceutical Co., Ltd.Enrolling: 2781 location
Postmenopausal Women With Osteoporosis at High Risk of Fracture
RECRUITINGPhase 3NCT07089186
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae...
The study will evaluate the efficacy and safety of Meropenem and Pralurbactam versus Best Available Therapy in the treatment of Carbapenem-Resistant Enterobacteriaceae Infections....
Sponsor: Qilu Pharmaceutical Co., Ltd.Enrolling: 801 location
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2